Literature DB >> 18950008

[Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].

Dewei Cui1, Xiangbao Zhang, Yafeng Fu.   

Abstract

OBJECTIVE: To study the expression of cyclooxygenase-2 (COX-2) and matrix metalloproteinase-2 (MMP-2) in nasopharyngeal carcinoma (NPC) and their relationship with lymph node metastasis.
METHOD: The expression of COX-2 and MMP-2 in 86 NPC tissues and 30 normal nasopharyngeal tissues were evaluated by immunohistochemical analysis. RESULT: The positive rate of COX-2 and MMP-2 in NPC tissue was 75.58% and 66.28% respectively, which was significantly higher than that in normal nasopharyngeal (P < 0.01). The expression of both COX-2 and MMP-2 were positively correlated with lymph node metastasis (P < 0.01). There was a positive correlation between the expression of COX-2 and MMP-2 (P < 0.01).
CONCLUSION: COX-2 and MMP-2 expression are increased in NPC, and they may cooperate in the course of lymph metastasis of NPC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950008

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  3 in total

Review 1.  Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Gui Yang; Qiaoling Deng; Wei Fan; Zheng Zhang; Peipei Xu; Shihui Tang; Ping Wang; Jun'e Wang; Mingxia Yu
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

2.  Matrix metalloproteinase 2 contributes to aggressive phenotype, epithelial-mesenchymal transition and poor outcome in nasopharyngeal carcinoma.

Authors:  Siyi Li; Weiren Luo
Journal:  Onco Targets Ther       Date:  2019-07-17       Impact factor: 4.147

3.  Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma.

Authors:  I-Che Chung; Lih-Chyang Chen; An-Ko Chung; Mei Chao; Hsin-Yi Huang; Chuen Hsueh; Ngan-Ming Tsang; Kai-Ping Chang; Ying Liang; Hsin-Pai Li; Yu-Sun Chang
Journal:  BMC Cancer       Date:  2014-05-20       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.